CTA-Sticky-button.png clinicaltrialsyearbook+button

8th Annual Clinical Operations in Oncology Trials East Coast 2018

11 – 12 July 2018, Boston, USA

After a successful event, Clinical Operations in Oncology Trials (CTO) is back for 2018 in the 7th year to bring together the clinical community. The CTO portfolio is the only operationally-focused oncology conference in the USA. Alongside our West Coast Conference, the East Coast conference in the Boston biotech hub is tailored specifically for Clinical Operations, Development, Research, and Medical Affairs pharma and biotech representatives in the region.

With a dynamic 2018 programme written for the industry, by the industry, this year promises to be more engaging and memorable than ever. Providing new insight into patient recruitment, regulatory compliance and harnessing the power of data analytics to ensure successful, timely and cost-effective oncology clinical trials. Remaining focused on how to operationally execute your clinical oncology trial most effectively to ensure the best results. For 2018 we have researched from within side the industry to find the issues which really matter to you to ensure the programme is tailored to the East Coast clinical challenges and interests

We look forward to welcoming you to the event in 2018 which promises to build upon the great foundation laid by the East Coast community year after year.

Guarantee your place for 2018 by registering now or contact us for more info!


Event News

Delving into Clinical Trials Insurance Billing Compliance

For this year’s event we will have insight from Douglas Reichgott, Director Financial and Regulatory Operations, Tufts Medical Center. Implementing a program to assure Clinical Trials Insurance Billing Compliance is sure to be a key session. Assessing insurance billing program risks to avoid action from the Federal Government including the Office of Inspector General.

Forming a new media partnership with MassBio

For the 2018 event this year we are thrilled to announce that we are partnering with MassBio.

Why this event is so important

Over 30% of all trials happening in the US at the moment are Oncology Trials. These trials are often run operationally different to most other trials due to the nature of oncology. Therefore addressing any issues head on and collaborating on the best way forward is the best way to improve trials.

Who should attend this event?

Given the speaker participation and delegates that attended in 2017, it is clear that this event attracts a range of pharma and biotech companies, small to large within the industry. The event attracts the best and most senior speakers in the industry, thus the sessions will be most relevant for senior professionals in the clinical industry.

Countdown to Clinical Operations in Oncology Trials East Coast 2018